Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study - London, W B; Frantz, C N; Campbell, L A (J Clin Oncol, 2010)
et al.